Successful Implementation of Bispecific Therapies: Expert Recommendations

Panelists discuss best practices for successfully implementing a bispecifics program and overcoming logistical challenges.

EP: 1.ASH 2024 Updates on Bispecific Therapies in B-Cell Lymphomas

EP: 2.Emerging Data for Odronextamab in DLBCL

EP: 3.Sequencing Consequences for Earlier Line Use of Bispecifics in B-Cell Lymphomas

EP: 4.Exploring Bispecifics in Earlier Lines of Therapy for B-Cell Lymphomas

EP: 5.ASH 2024 Highlights: Bispecifics in Combination Therapies for B-Cell Lymphomas

EP: 6.MAIC Analyses and Bispecific Therapies: Guiding Treatment Decisions in B-Cell Lymphomas

EP: 7.Understanding CRS and ICANS: Real-World Incidence and Key Patient Risk Factors

EP: 8.Key Strategies for Preventing CRS and ICANS

EP: 9.Step-Up Dosing Protocols and Infection Prevention Strategies for Bispecifics in B-Cell Lymphomas

EP: 10.Overcoming Logistical Hurdles in Bispecific Therapy Implementation

Now Viewing

EP: 11.Successful Implementation of Bispecific Therapies: Expert Recommendations

Video content above is prompted by the following:

1. What best practices can you share for successfully implementing a bispecifics program and overcoming these challenges? (Ms Chang)

Related Videos

Related Content

Advertisement

September 23rd 2022

A Population Health Approach to Managing Heart Failure

Related Content

Advertisement

September 23rd 2022

A Population Health Approach to Managing Heart Failure